(Seoul=NSP News Agency) dILFUZA Sultanova Journalist = Hyundai IBT (representative Oh Sang Ki) held the groundbreaking ceremony of extension work on June 9 of Bio-industrial complex in order to complete construction works in late November.

Hyundai IBT, planned to increase its existing production capacity fourfold by extending the production line to 300, based on new materials of Vitabrid powder. About 4.3 billion dollars have been allocated.

In the future, in preparation for the performance as a leading manufacturer of pharmaceutical industry, it planned to set up production of high quality system assessing the KGMP and implementation of automated facilities and equipment.

The representative of Hyundai IBT, Oh Sang Kee said “The expansion production capacities of Gimcheon Bio-factory means that, built a mass production system, which is ahead of new players of Europe and US markets by increasing the volume of sales on the markets of Korea, China, Japan and other Asian countries”, “In the future, the company also plans significantly reinforce marketing surveys to increase exports and dominate in the domestic market”.